Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Compounded tirzepatide (GLP/GIP) Tirzepatide is a dual-action medication that targets both GLP-1 and GIP receptors, making it potentially more effective than semaglutide alone
This adaptable approach allows you to test market response without significant upfront investment, making it easier to adjust to evolving consumer trends and demands
This time, instead of testing the drug on patients with type 2 diabetes, the drug was tested on patients without diabetes to specifically monitor their weight
For oral administration, clinical trials have studied doses ranging from 1-30 mg daily, with typical protocols using 1-2 mg per dose on an empty stomach
If your PCM is unfamiliar with GLP-1 agonists or prefers to manage diabetes with older medications, obtaining a referral to endocrinology can add weeks to the process
Discuss your work schedule and sleep pattern with your PlexusDx clinician to find the timing that minimizes side effects while maintaining medication effectiveness
US$ 23.17
US$ 25.16
US$ 29.49
